CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been ...

A bundle of healthcare legislation that would introduce greater oversight of the pharmacy benefit manager (PBM) sector is reported to be close to an agreement by US lawmakers. The package ...